WO2004101820A3 - Gene sah comme marqueur du psoriasis - Google Patents

Gene sah comme marqueur du psoriasis Download PDF

Info

Publication number
WO2004101820A3
WO2004101820A3 PCT/FR2004/001064 FR2004001064W WO2004101820A3 WO 2004101820 A3 WO2004101820 A3 WO 2004101820A3 FR 2004001064 W FR2004001064 W FR 2004001064W WO 2004101820 A3 WO2004101820 A3 WO 2004101820A3
Authority
WO
WIPO (PCT)
Prior art keywords
psoriasis
marker
sah gene
sah
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2004/001064
Other languages
English (en)
Other versions
WO2004101820A2 (fr
Inventor
Valerie Trinquet
Patricia Rossio
Michel Demarchez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Publication of WO2004101820A2 publication Critical patent/WO2004101820A2/fr
Publication of WO2004101820A3 publication Critical patent/WO2004101820A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention a pour objet l'utilisation d'une sonde relative au gène SAH pour la caractérisation d'un échantillon biologique. L'invention a également pour objet l'utilisation de cette sonde pour l'identification d'un composé destiné au traitement du psoriasis, un procédé d'identification ainsi qu'un nouvel outil de recherche.
PCT/FR2004/001064 2003-05-07 2004-05-03 Gene sah comme marqueur du psoriasis Ceased WO2004101820A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR03/05571 2003-05-07
FR0305571A FR2854639A1 (fr) 2003-05-07 2003-05-07 Genes du psoriasis.

Publications (2)

Publication Number Publication Date
WO2004101820A2 WO2004101820A2 (fr) 2004-11-25
WO2004101820A3 true WO2004101820A3 (fr) 2005-01-20

Family

ID=33306221

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2004/001064 Ceased WO2004101820A2 (fr) 2003-05-07 2004-05-03 Gene sah comme marqueur du psoriasis

Country Status (2)

Country Link
FR (1) FR2854639A1 (fr)
WO (1) WO2004101820A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0955382A2 (fr) * 1998-05-07 1999-11-10 Affymetrix, Inc. (a California Corporation) Des polymorphismes associés à l'hypertension
WO2002044201A2 (fr) * 2000-12-01 2002-06-06 Genaissance Pharmaceuticals, Inc. Haplotypes du gene sah

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0955382A2 (fr) * 1998-05-07 1999-11-10 Affymetrix, Inc. (a California Corporation) Des polymorphismes associés à l'hypertension
WO2002044201A2 (fr) * 2000-12-01 2002-06-06 Genaissance Pharmaceuticals, Inc. Haplotypes du gene sah

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BOWCOCK A M ET AL: "Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies", HUMAN MOLECULAR GENETICS, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 10, no. 17, 15 August 2001 (2001-08-15), pages 1793 - 1805, XP002265788, ISSN: 0964-6906 *
DATABASE EMBL EBI; 28 October 2004 (2004-10-28), XP002304965, Database accession no. NM_005622 *
IWAI NAOHARU ET AL: "Association between SAH, an acyl-CoA synthetase gene, and hypertriglyceridemia, obesity, and hypertension", CIRCULATION, AMERICAN HEART ASSOCIATION, DALLAS, TX, US, vol. 105, no. 1, 1 January 2002 (2002-01-01), pages 41 - 47, XP001105333, ISSN: 0009-7322 *
NABIKA T ET AL: "Evaluation of the SA locus in human hypertension", HYPERTENSION, vol. 25, no. 1, 1995, pages 6 - 13, XP001104818, ISSN: 0194-911X *
OESTREICHER J L ET AL: "Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling", PHARMACOGENOMICS JOURNAL, NATURE PUBLISHING GROUP, GB, vol. 1, no. 4, 2001, pages 272 - 287, XP008036398, ISSN: 1470-269X *
PRADET-BALADE B ET AL: "Translation control: bridging the gap between genomics and proteomics?", TIBS TRENDS IN BIOCHEMICAL SCIENCES, ELSEVIER PUBLICATION, CAMBRIDGE, EN, vol. 26, no. 4, 1 April 2001 (2001-04-01), pages 225 - 229, XP004233580, ISSN: 0968-0004 *
ZHOU XIANGHONG ET AL: "Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array.", PHYSIOLOGICAL GENOMICS. 18 MAR 2003, vol. 13, no. 1, 18 March 2003 (2003-03-18), pages 69 - 78, XP002304964, ISSN: 1531-2267 *

Also Published As

Publication number Publication date
FR2854639A1 (fr) 2004-11-12
WO2004101820A2 (fr) 2004-11-25

Similar Documents

Publication Publication Date Title
WO2006137932A3 (fr) Detection homogene de substance a analyser
WO2003062462A3 (fr) Methode permettant d'isoler des acides nucleiques et des proteines contenus dans un echantillon unique
WO2001051654A3 (fr) Procedes et assortiments de materiel permettant d'identifier l'evenement elite gat-zm1 dans les echantillons biologiques
WO2004052175A3 (fr) Procedes pour l'identification rapide de pathogenes chez les humains et chez les animaux
SI1871901T1 (sl) Elitni dogodek A5547-127 ter postopki in kompleti za identificiranje takega dogodka v bioloških vzorcih
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
WO2004055519A3 (fr) Marqueurs specifiques pour le cancer du pancreas
EP1323728A3 (fr) Méthode pour préparer un standard diagnostique pour un motif de transcription génétique
WO2007019899A8 (fr) Method for predicting the response to a treatment
WO2006132971A3 (fr) Identification de tumeurs et de tissus
WO2005087951A3 (fr) Reactifs, procedes et kits utilise dans la desactivation d'acides nucleiques
WO2005054516A3 (fr) Sondes d'acides nucleiques peptidiques pour l'analyse de certaines especes staphylococcus
EP2006393A4 (fr) Procede d'analyse d'acides nucleiques
WO2003078603A3 (fr) Ensembles de genes forts pour classification de gliomes
WO2005027710A3 (fr) Procedes d'identification de sujets a risque pour le melanome et traitements correspondants
AU2003211867A1 (en) Novel method of highly sensitive nucleic acid analysis
AUPS064202A0 (en) Improved method for the analysis of nucleic acid samples
AU2003285775A1 (en) Method for identifying, analyzing and/or cloning nucleic acid isoforms
WO2004094661A3 (fr) Genes fancc, dad1, grim19 et hadhii marquers du psoriasis
WO2006125012A3 (fr) Compositions, procedes et kits permettant l'analyse en temps reel d'acides nucleiques dans des cellules vivantes
WO2004094660A3 (fr) Gene dpysl3 comme marqueur du psoriasis
EP1323835A3 (fr) Méthode pour la détection d'une espèce biologique dans un échantillon d'essai et trousse utilisée pour la dite méthode
AU2003270814A1 (en) Method of extracting nucleic acids from microbial samples
AU2003292013A1 (en) Method for conducting the parallel identification of different nucleic acids
AU2003266197A1 (en) Method for the detection of nucleic acid sequences by means of crackable probe molecules

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase